The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Merrimack Pharmaceuticals

  • MACK
  • NASDAQ
  • Consumer Products
  • Latest 6.79
  • Currency US$
  • Change -0.06
  • Percent Change -0.876 %
  • Volume 519,181
  • Fri Jul 11, 2014 02:31 PM EDT NASDAQ data delayed 15 minutes.
  • Open 6.86
  • Previous Close 6.85
  • High 6.93
  • Low 6.72
  • Bidx10 6.79
  • Askx33 6.80
  • 52-week High05/29 8.25
  • 52-week Low11/06 2.05
  • Beta 0.983
  • Market Cap
  • EPS -1.30
  • P/E
  • Forward P/E
  • PEG
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales n/a
  • Earnings n/a
  • Return on Equity n/a

Cash Flow

  • Cash Flow n/a
  • Cash n/a
  • Current Ratio n/a

12 months ended n/a.

Trailing 12 month results shown above.
All data is in dollars.

Balance Sheet

  • Assets n/a
  • Liabilities n/a
  • Liabilities-to-Equity Ratio n/a

Price Ratios

  • Price to Sales n/a
  • Price to Book n/a
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings May 12 $-0.31 Aug 14 $-0.32
Surprises May 12 -12.90% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Jul 11, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Related Securities
Symbol Type Latest % Chg

Officers

  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: n/a,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

No address found.

Ideas & Discussion

Live Discussion of MACK on StockTwits